A Plain Language Summary of the Final Analysis of the Griffin Study of Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone for People With Newly Diagnosed Multiple Myeloma

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.